Towards Healthcare
Antipsychotic Drugs Market Size, Companies and Growth

Antipsychotic Drugs Market Size Envisioned at USD 37.40 Billion by 2032

The report covers Antipsychotic Drugs Market Size and Companies such as Otsuka Holdings Co., Ltd., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Dr. Reddy's Laboratories Limited, AstraZeneca PLC, Johnson & Johnson, Pfizer Inc., Alkermes Plc., AbbVie Inc. and Bristol-Myers Squibb. Segmented by therapeutic class into first and second generation drugs, Applications includes schizophrenia, dementia, bipolar disorder, depression and other applications. Distribution channels include hospital, retail and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antipsychotic Drugs Market Assessment

  • Overview
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Antipsychotic Drugs Market Assessment

  • Overview
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Europe Antipsychotic Drugs Market Assessment

  • Overview
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Asia Pacific Antipsychotic Drugs Market Assessment

  • Overview
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Middle East and Africa Antipsychotic Drugs Market Assessment

  • Overview
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

South America Antipsychotic Drugs Market Assessment

  • Overview
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Company Profiles

  • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Dr. Reddy's Laboratories Limited
  • AstraZeneca PLC.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Pfizer Inc.
  • Alkermes Plc.
  • AbbVie Inc. (Allergan Inc.)
  • Bristol-Myers Squibb

Conclusion & Recommendations

  • Insight Code: 5147
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Rising prevalence of mental illnesses like schizophrenia and bipolar disorder, Growing geriatric population with increased risk of dementia and Increasing government initiatives for mental healthcare awareness and access to medication.

Asia Pacific, due to growing awareness, rising disposable income, and development of local pharmaceutical industries.

Generic alternatives will become available, making treatment more affordable and potentially expanding market reach.

World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention, HHS.gov. and ScienceDirect.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515